Breakout Labs
Venture capitalSeed–Series A
Investment thesis
Breakout invests at the frontier where science and technology intersect, backing founders scaling scientific innovation across biotech, tech-bio, deep tech, hard tech, and chemistry-driven technology. With more than a decade of experience, its team of scientists and operators brings technical depth and commercial fluency to anticipate roadblocks and navigate complexity. Beyond capital, Breakout leverages a catalytic network of corporates, strategic partners, and next-stage investors to help portfolio companies gain traction, reach milestones faster, and scale into category-defining businesses.
Source: firm website, verified Aug 7, 2026.
What they invest in
from 8 of 10 portfolio companiesBiotech ×7Deep Tech ×3New Materials ×3Circular Economy ×2Digital Health ×2Healthtech ×2Medical Devices ×2AI & Machine Learning ×1
HQs:United States×5
Investments · 10 tracked
founders shown can be your intro path
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ajay Shah(Co-founder & CEO)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)
BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in
Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout VenturesEMV CapitalIT-Farm Corporation+3 more
STRM.BIO develops a gene therapy delivery platform based on megakaryocyte-derived extracellular vesicles (STRM MVs) that target and deliver genetic cargoes preferentially to bone marrow and hematopoietic stem cells.
BiotechDeep TechMedical Devices
Co-investorsAscension VenturesBreakout VenturesDelos CapitalNYBC VenturesKdT Ventures
Ecovative grows whole-cut meat alternatives and other materials from mycelium using its AirMycelium indoor cultivation platform, which integrates with existing mushroom farming infrastructure.
BiotechFoodTechNew MaterialsGreen Island, US
Gavin McIntyre(Executive Officer, Director)Eben Bayer(Executive Officer, Director)
BoardEvan Lodes(Director)Jerry Weinstein(Director)Charles Deull(Director)Jessica Harris(Director)
Co-investorsBreakout VenturesStray Dog Capital
Epana Bio develops therapies for autoimmune diseases by leveraging genomics and AI to identify and target cellular origins of disease, with a focus on precision medicine for patient populations.
AI & Machine LearningBiotechDigital Health
Co-investorsBreakout VenturesHAWKTAILHummingbird VenturesOMX VenturesKdT VenturesRefactor Capital
Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient.
BiotechDeep TechHealthtechSeattle, US
Matthew Scholz(Founder)Sean Ainsworth(Chief Executive Officer)Robert Sikorski(Chief Medical Officer)Rob Hayes(Chief Scientific Officer)Scott McIvor(Chief Development Officer)Richard Chin, M.D.(Director)
Co-investorsBioRock VenturesBoston Harbor AngelsBreakout VenturesEQx FundInvariantes FundMichigan Capital Network+1 more
Modern Meadow develops animal-free, bio-fabricated leather alternatives using synthetic biology and material science for the fashion, interiors, and automotive industries.
BiotechCircular EconomyNew MaterialsPine Brook, US
Gabor Forgacs(Director, Promoter)Anna Bakst(Executive Officer, Director)Rex Liu(Executive Officer)
BoardAndras Forgacs(Director, Promoter)Bart Swanson(Director)inKlaus Hommels(Director)
Co-investorsArtis VenturesAstanor VenturesBreakout VenturesHorizons VenturesInventus Capital PartnersKohala Ventures+4 more
Training foundation models to develop cancer immunotherapies
Transforming carbon dioxide emissions into useful chemicals
ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.
BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US
Harshal Chokhawala(Founder & CEO)
Co-investorsAccelr8Breakout VenturesCavallo VenturesDudley FundFreshTracks CapitalPrime Partners+4 more
Portfolio news
latest coverage across their companies
▶︎ CYTOVALE · funderintel.com · Jul 16, 2026
Immusoft · immusoft.com · Mar 30, 2026
Frequently asked questions
- How many investments has Breakout Labs made?
- Breakout Labs has 8 tracked investments.
- What stage does Breakout Labs invest at?
- Breakout Labs invests at the Seed, Series A stages.
- What sectors does Breakout Labs focus on?
- Breakout Labs focuses on AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Hardware, Healthtech, New Materials.
- Does Breakout Labs lead rounds?
- Breakout Labs typically participates in rounds rather than leading them.
- Who does Breakout Labs co-invest with?
- Breakout Labs most often shares deals with Breakout Ventures, Artis Ventures, Horizons Ventures, among 28 tracked co-investors.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Refactor is a seed-stage venture firm run as a solo capitalist by Zal, backing founders building hard tech companies that address real-world problems.
Alpha Edison is an investment firm that partners with entrepreneurs to build category-creating companies that open up new markets.
Freeflow is a venture capital firm founded in 2019, initially focused on the entrepreneurial community at Caltech, that invests in early-stage, science-driven deep tech companies.
Fundamental Ventures is an early-stage venture firm that backs founders removing fundamental constraints holding back human progress, spanning hard tech, deep science, and network/workflow innovations.